• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过引导选择实现人源化。

Humanization by guided selections.

作者信息

Kim Sang Jick, Hong Hyo Jeong

机构信息

Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Gwahangno, Yuseong-gu, Daejeon, Republic of Korea.

出版信息

Methods Mol Biol. 2012;907:247-57. doi: 10.1007/978-1-61779-974-7_14.

DOI:10.1007/978-1-61779-974-7_14
PMID:22907356
Abstract

Guided selection provides a powerful tool for humanization of the preexisting nonhuman antibodies as exemplified by HUMIRA, the world's first human antibody approved. This chapter describes the sequential guided selection procedure in which mouse VL and VH domains are replaced sequentially with human VL and VH, respectively to derive completely human antibody. The detailed protocols for construction of phage-displayed antibody library, panning, screening, and characterization, are included to achieve successful selection of human antibody with similar characteristics to original mouse antibody.

摘要

定向筛选为将已有的非人源抗体人源化提供了一种强大的工具,如全球首个获批的人源抗体修美乐(HUMIRA)所示。本章描述了顺序定向筛选程序,其中小鼠VL和VH结构域分别依次被人源VL和VH取代,以获得完全人源化抗体。文中还包括构建噬菌体展示抗体文库、淘选、筛选和鉴定的详细方案,以成功筛选出与原始小鼠抗体具有相似特性的人源抗体。

相似文献

1
Humanization by guided selections.通过引导选择实现人源化。
Methods Mol Biol. 2012;907:247-57. doi: 10.1007/978-1-61779-974-7_14.
2
Selection of non-aggregating VH binders from synthetic VH phage-display libraries.从合成的VH噬菌体展示文库中筛选非聚集性VH结合物。
Methods Mol Biol. 2009;525:187-216, xiii. doi: 10.1007/978-1-59745-554-1_10.
3
Design of a human synthetic combinatorial library of single-chain antibodies.人源单链抗体合成组合文库的设计
Methods Mol Biol. 2009;525:61-80, xiv. doi: 10.1007/978-1-59745-554-1_3.
4
Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.基于人抗体单可变轻链结构域构建针对B7.1和B7.2的新型结合配体。
J Mol Biol. 2001 Jul 13;310(3):591-601. doi: 10.1006/jmbi.2001.4703.
5
Generation of human single domain antibody repertoires by Kunkel mutagenesis.通过昆克尔诱变产生人单域抗体库。
Methods Mol Biol. 2012;907:195-209. doi: 10.1007/978-1-61779-974-7_10.
6
In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.通过复性在噬菌体表面进行抗体链文库的体外组装。
J Mol Biol. 1994 May 27;239(1):68-78. doi: 10.1006/jmbi.1994.1351.
7
Fabs specific for 8-oxoguanine: control of DNA binding.对8-氧代鸟嘌呤具有特异性的Fab片段:DNA结合的控制
J Mol Biol. 1999 Nov 12;293(5):1085-95. doi: 10.1006/jmbi.1999.3214.
8
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.人源组合抗体文库HuCAL GOLD将基于天然免疫系统的所有六个互补决定区(CDR)的多样化与一种用于高效筛选高亲和力抗体的新型展示方法结合在一起。
J Mol Biol. 2008 Feb 29;376(4):1182-200. doi: 10.1016/j.jmb.2007.12.018. Epub 2007 Dec 15.
9
Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.一种在重链可变区进行糖基化修饰的抗人白细胞介素-6小鼠单克隆抗体的人源化。
Hum Antibodies Hybridomas. 1996;7(4):175-83.
10
Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.通过指导选择一种泛癌特异性抗体发现,原始鼠源抗体与其人源等效抗体之间具有相似的结合特性,但结构存在差异。
J Mol Biol. 2000 Feb 25;296(3):833-49. doi: 10.1006/jmbi.2000.3512.

引用本文的文献

1
Phage Display Technology as a Powerful Platform for Antibody Drug Discovery.噬菌体展示技术作为一种强大的抗体药物发现平台。
Viruses. 2021 Jan 25;13(2):178. doi: 10.3390/v13020178.
2
Generation, Diversity Determination, and Application to Antibody Selection of a Human Naïve Fab Library.生成、多样性测定及人源天然 Fab 库在抗体选择中的应用。
Mol Cells. 2017 Sep 30;40(9):655-666. doi: 10.14348/molcells.2017.0106. Epub 2017 Sep 20.